New Research Explains Why Women Are More Vulnerable to Alzheimer’s

Women are twice as likely as men to develop Alzheimer’s disease — but scientists are still trying to understand why.

One key reason: Women were historically excluded from medical research. It wasn’t until 1993 that U.S. lawmakers required federally funded studies to include women. Researchers have been working to close that knowledge gap ever since.

Now, new research is helping scientists better understand why women’s brains may be more vulnerable to Alzheimer’s — and what might help lower the risk.

Alzheimer’s tau tangles build up faster in women

In Alzheimer’s disease, toxic proteins called beta-amyloid and tau form in the brain, disrupting normal function. But could these proteins build up faster in women?

A new study in JAMA Neurology tracked tau levels in 1,376 healthy older adults over three years, focusing on those with high beta-amyloid levels — a known Alzheimer’s risk factor. The results showed that women at risk developed tau tangles faster than men.

Since tau buildup is linked to cognitive decline, this may help explain why women are more likely to develop Alzheimer’s.

Early menopause could speed up the disease

Estrogen, a hormone that supports brain health, may play a key role in Alzheimer’s risk. Could an early drop in estrogen — such as through early menopause — trigger damaging changes in the brain?

A study of 268 women in the Rush Memory and Aging Project found that those who experienced menopause before age 50 had more tau tangles and worse synaptic integrity — a measure of how well brain cells connect and communicate. The findings highlighted the importance of hormone replacement therapy after menopause and added to evidence that estrogen may protect the brain.

Blood vessels in women’s brains age differently

The blood vessels that supply the brain with oxygen and nutrients age over time, a process known as angiogenesis. More new research suggests this process may affect women’s brains differently.

A recent study in Science Translational Medicine measured angiogenesis biomarkers in healthy adults and found that higher levels were linked to better cognitive performance in younger women — but worse performance in older women. This pattern wasn’t seen in men.

Understanding why women are more vulnerable to Alzheimer’s is a crucial step toward catching the disease early and developing targeted treatments.

Facebook
Twitter
Email
LinkedIn
Pinterest

Related Articles

Blood Tests for Alzheimer’s

Unlike conditions like high blood pressure or diabetes, there is no quick and easy test to diagnose Alzheimer’s disease accurately. It often takes several years

Read More »

Stem Cells for Dementia

Since their discovery in the 1960s, stem cells have captivated our curiosity. Unlike other cells in the body, stem cells are changeable: They can self-renew,

Read More »

K2 is Closed for the holidays

All K2 locations will be closed from December 24, 2024 – January 5, 2025.  We will reopen on January 6, 2025.  In the meantime, please check out our website to learn more about our clinical research trials, our teams, and ways you can join our growing team.  

Wishing you and your families a Happy Holiday Season! 

Melissa Belardo, APRN

Clinical Investigator

Melissa Belardo, is a certified family nurse practitioner (FNP-BC), joins K2 Medical Research with more than a decade of clinical experience. She has served as an investigator in over 20 trials. Prior to clinical research, she held roles in gastroenterology, hepatology, and nurse education.

Melissa’s academic background includes a Bachelor of Science in Nursing from Adventist University, followed by a master’s degree in Family Nurse Practitioner from Georgetown University.

Melissa is a native of the US Virgin Islands’ and is fluent in both English and Spanish; Melissa has lived in central Florida for the past twenty years. When she’s not at work, you can find her volunteering at her local church and spending time with family.

Join a Study

If you are interested in learning more or participating in any of our studies, please fill out the form below and our office will get back to you within 1-2 business days.